Johnson & Johnson announced on Thursday that it would begin largest, late-stage trial testing a potential coronavirus vaccine in September. The phase three trial would enroll up to 60,000 healthy people ages 18 and older across nearly 180 locations in the U.S. and other countries, according to a J&J spokesman and ClinicalTrials.gov. The participants will … Continue reading “Johnson & Johnson to Start Late-stage Coronavirus Vaccine Trial Next Month”
